熱門資訊> 正文
CyclomX Therapeutics提拔Chris Ogden为CFO
2024-06-18 04:31
- CytomX醫療(CTMX) 0
- 禮來(LLY) 0
- 鮑爾包裝(BLL) 0
- CytomX Therapeutics (NASDAQ:CTMX) on Monday announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024.
- Ogden joined CytomX in August 2021 as Vice President, Finance and Accounting. He joined the company after a 16-year tenure at Eli Lilly, where he held senior financial leadership positions, including most recently as CFO of Lilly Diabetes.
- CTMX -2.18% after hours to $1.34.
- Source: Press Release.
More on CytomX
- CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling
- CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
